Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Altered hippocampal volume, the brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism, and neuroticism have each been implicated in the etiology of psychiatric disorders, especially depression. However, the relationship between these variables is not well understood. Here, we determined the effects of the BDNF Val66met polymorphism on the five‐factor personality dimensions (assessed using the NEO‐FFI), trait depression (assessed with the DASS‐21) in a cross‐sectional cohort of 467 healthy volunteers. A large matched subset of this cohort was also assessed for grey matter volume of the hippocampus and contiguous temporal cortical regions using magnetic resonance imaging. In Met carriers, elevations in neuroticism and trait depression and stress were associated with lower mean hippocampal volume, but there were no such associations in Val homozygotes. Trait depression, in particular, was found to moderate the effects of BDNF genotypes on hippocampal volume. Met carriers with high trait depression showed a reduction in grey matter volume of the mean hippocampus compared with Val homozygotes. These findings suggest that even in otherwise healthy subjects, trait depression may contribute to the susceptibility of Met carriers to hippocampal grey matter loss. Hum Brain Mapp 2009. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 1×
“…using the BRID personal history and screening assessments, which include the SPHERES [Hickie et al., 1998] and Patient Health Questionnaire (PHQ9) [Kroenke and Spitzer, 2002] to screen for symptoms of Axis-1 disorder, the AUDIT (Alcohol Use Disorders Identification Test of the WHO) and Fagerstrom…”
MethodHenry, J. D., & Crawford, J. R. (2005) · British Journal of Clinical Psychology · doi:10.1348/014466505x29657 · Cited by 5,801
Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998) · Psychological Assessment · doi:10.1037/1040-3590.10.2.176 · Cited by 4,874 · cited 2×
“Established norms include Australian, US, and UK populations [Antony et al., 1998; Crawford and Henry, 2003; Henry and Crawford, 2005; Lovibond and Lovibond, 1995].”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“It has been found to alter hippocampal function and memory processes [Bueller et al., 2006; Egan et al., 2003; Hariri et al., 2003; Nemoto et al., 2006; Pezawas et al., 2004; Szeszko et al., 2005].”
BackgroundNormal personality assessment in clinical practice: the NEO personality inventory
Costa, P. T., & McCrae, R. R. (1992) · Psychological Assessment · doi:10.1037/1040-3590.4.1.5 · Cited by 3,414
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Crawford, J. R., & Henry, J. D. (2003) · British Journal of Clinical Psychology · doi:10.1348/014466503321903544 · Cited by 1,756 · cited 2×
“Established norms include Australian, US, and UK populations [Antony et al., 1998; Crawford and Henry, 2003; Henry and Crawford, 2005; Lovibond and Lovibond, 1995].”
BackgroundJACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Cited by
Pechtel, P., & Pizzagalli, D. A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2009-2 · Cited by 1,352
“For example, Met carriers of the BDNF polymorphism were found to exhibit smaller hippocampal volumes in the presence of stress, trait depression and neuroticism (Joffe et al. 2009).”
BackgroundDannlowski, U., Stuhrmann, A., Beutelmann, V., Zwanzger, P., Lenzen, T., Grotegerd, D., Domschke, K., Hohoff, C., Ohrmann, P., Bauer, J., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.021 · Cited by 954
Major depressive disorder: new clinical, neurobiological, and treatment perspectives
Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894
MacQueen, G., & Frodl, T. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.80 · Cited by 665
Gatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H., Bryant, R. A., Schofield, P. R., Gordon, E., Kemp, A. H., & Williams, L. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.143 · Cited by 525
Self-citation
Metadata
- Authors
- Joffe, R. T., Gatt, J. M., Kemp, A. H., Grieve, S., Dobson‐Stone, C., Kuan, S. A., Schofield, P. R., Gordon, E., & Williams, L. M.
- Venue
- Human Brain Mapping
- Publisher
- Wiley
- Published
- 2008-06-11
- Volume
- 30
- Issue
- 4
- Pages
- 1246-1256
- ISSN
- 1065-9471 (ISSN-L)
- 1097-0193
- OpenAlex
- W2051550544
- Cited by
- 79
- References
- 25
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. https://app.cochat.ai/papers/10.1002/hbm.20592
- The paper
- Joffe, R. T., Gatt, J. M., Kemp, A. H., Grieve, S., Dobson‐Stone, C., Kuan, S. A., Schofield, P. R., Gordon, E., & Williams, L. M. (2009). Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness. Human Brain Mapping. https://doi.org/10.1002/hbm.20592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.